Association between Northern Manhattan study global vascular risk score and successful aging

Journal of the American Geriatrics Society

Volumn 61, Issue 4, 2013, Pages 519-524

  Warsch, Jessica R L ^a   Rundek, Tatjana ^a   Paik, Myunghee C ^b   Elkind, Mitchell S V ^b,c   Sacco, Ralph L ^a   Wright, Clinton B ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Columbia University ^*  (United States)

^c NONE   (United States)

Author keywords

cognitive aging; global vascular risk; successful aging; vascular risk factors

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCOSE;

AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; AGING; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; CLAUDICATION; CLINICAL ASSESSMENT TOOL; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; DEATH; DIASTOLIC BLOOD PRESSURE; DISABILITY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; FEMALE; FOLLOW UP; GLOBAL VASCULAR RISK SCORE; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HISPANIC; HUMAN; IMAGE ANALYSIS; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PHYSICAL ACTIVITY; POPULATION RESEARCH; PROSPECTIVE STUDY; RACE DIFFERENCE; SEX DIFFERENCE; SMOKING; SOCIOECONOMICS; SUBSEQUENT COGNITIVE DECLINE; VASCULAR DEATH; WAIST CIRCUMFERENCE;

AGE OF ONSET; AGED; AGED, 80 AND OVER; COGNITION DISORDERS; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; HYPERTENSION; MALE; PREVALENCE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE; UNITED STATES; VASCULAR DISEASES;

EID: 84876287811     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12166     Document Type: Article

References (37)

1. Rowe JW, Kahn RL,. Successful Aging. New York: Dell Publishing, 1998.
2. Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42: 2672-2713, [Review].
3. Beeri MS, Ravona-Springer R, Silverman JM, et al. The effects of cardiovascular risk factors on cognitive compromise. Dialogues Clin Neurosci 2009; 11: 201-212.
4. Greenlund KJ, Zheng ZJ, Keenan NL, et al. Trends in self-reported multiple cardiovascular disease risk factors among adults in the United States, 1991-1999. Arch Intern Med 2004; 164: 181-188.
5. Kivipelto M, Ngandu T, Fratiglioni L, et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 2005; 62: 1556-1560.
6. Yaffe K, Kanaya A, Lindquist K, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004; 292: 2237-2242.
7. Vieira JR, Elkind MS, Moon YP, et al. The metabolic syndrome and cognitive performance: The Northern Manhattan Study. Neuroepidemiology 2011; 37: 153-159.
8. D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation 2008; 117: 743-753.
9. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847.
10. Ridker PM, Buring JE, Rifai N, et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The Reynolds Risk Score. JAMA 2007; 297: 611-619.
11. Sacco RL, Khatri M, Rundek T, et al. Improving global vascular risk prediction with behavioral and anthropometric factors: The multi-ethnic Northern Manhattan Cohort Study. J Am Coll Cardiol 2009; 54: 2303-2311.
12. Depp CA, Jeste DV,. Definitions and predictors of successful aging: A comprehensive review of larger quantitative studies. Am J Geriatr Psychiatry 2006; 14: 6-20.
13. Cockcroft DW, Gault MH,. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
14. Nickolas TL, Khatri M, Boden-Albala B, et al. The association between kidney disease and cardiovascular risk in a multi-ethnic cohort: Findings from the Northern Manhattan Study (NOMAS). Stroke 2008; 39: 2876-2879.
15. Khatri M, Nickolas T, Moon YP, et al. CKD associates with cognitive decline. J Am Soc Nephrol 2009; 20: 2427-2432.
16. Etgen T, Sander D, Chonchol M, et al. Chronic kidney disease is associated with incident cognitive impairment in the elderly: The INVADE Study. Nephrol Dial Transplant 2009; 24: 3144-3150.
17. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
18. Tombaugh TN, McDowell I, Kristhansson B, et al. Mini-Mental State Examination (MMSE) and the Modified MMSE (3MS): A psychometric comparison and normative data. Psychol Assess 1996; 8: 48-59.
19. Crum RM, Anthony JC, Bassett SS, et al. Mini-Mental State Examination by age and educational level. JAMA 1993; 269: 2386-2391.
20. Das D, Orengo CA, Kunik ME, et al. Cognitive decline in patients on an acute geropsychiatric unit. J Neuropsychiatry Clin Neurosci 1998; 10: 205-209.
21. Marzona I, O'Donnell M, Teo K, et al. Increased risk of cognitive and functional decline in patients with atrial fibrillation: Results of the ONTARGET and TRANSCEND studies. Can Med Assoc J 2012; 184: E329-E336.
22. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-1847.
23. Chang M, Hahn RA, Teutsch SM, et al. Multiple risk factors and population attributable risk for ischemic heart disease mortality in the United States, 1971-1992. J Clin Epidemiol 2001; 54: 634-644.
24. Sullivan PW, Ghushchyan V, Wyatt HR, et al. Impact of cardiometabolic risk factor clusters on health-related quality of life in the U.S. Obesity 2007; 15: 511-521.
25. Sullivan PW, Ghushchyan V,. Cardiovascular risk factor clusters and employment in the United States. Value Health 2007; 10: S52-S58.
26. Daviglus ML, Liu K, Greenland P, et al. Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to Medicare costs. N Engl J Med 1998; 339: 1122-1129.
27. Kuller LH, Velentgas P, Barzilay J, et al. Diabetes mellitus: Subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality. Arterioscler Thromb Vasc Biol 2000; 20: 823-829.
28. Newman AB, Gottdiener JS, McBurnie MA, et al. Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci 2001; 56A: M158-M166.
29. Rafnsson SB, Deary IJ, Fowkes FGR,. Peripheral arterial disease and cognitive function. Vasc Med 2009; 14: 51-61.
30. Rehring TF, Sandhoff BG, Stolcpart RS, et al. Atherosclerotic risk factor control in patients with peripheral arterial disease. J Vasc Surg 2005; 41: 816-822.
31. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 6: 1105-1187.
32. Tsivgoulis G, Alexandrov AV, Wadley VG, et al. Association of higher diastolic blood pressure levels with cognitive impairment. Neurology 2009; 73: 589-595.
33. Blacher J, Evans A, Arveiler D, et al. Residual cardiovascular risk in treated hypertension and hyperlipidaemia: The PRIME Study. J Hum Hypertens 2010; 24: 19-26.
34. Novak V, Hajjar I,. The relationship between blood pressure and cognitive function. Nat Rev Cardiol 2010; 7: 686-698.
35. Bonow RO, Smaha LA, Smith SC Jr, et al. World Heart Day 2002: The international burden of cardiovascular disease: Responding to the emerging global epidemic. Circulation 2002; 106: 1602-1605.
36. National Center for Health Statistics. Health, United States, 2001 with Urban and Rural Health Chartbook (DHHS publication 01-1232). Hyattsville, MD: Department of Health and Human Services, Centers for Disease Control and Prevention, 2001.
37. American Heart Association. 2002 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association, 2001.